Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06330870

Brain Metastasis Development Mechanism in BCBM Patients

This study is the experimental study for brain metastasis development mechanism in patients with breast cancer with brain metastasis

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Ji-Yeon Kim

Seoul, 06351, South Korea

Location status: Recruiting

Location contact

Ji-Yeon Kim

CONTACT

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Breast cancer
  • Brain metastasis curative surgery patient

Exclusion criteria

  • Gamma Knife surgery patient

Treatment and study plan

WGS/TME evaluation

Procedure

WGS/TME evaluation with blood and brain metastasis tissue during brain metastasis curative surgery

Primary outcomes

  1. Intracranial disease free survival

    Time frame: Months

    Time to new brain metastasis or brain metastasis progression from the brain surgery

Study contacts

Contact information is provided by the study sponsor or research team.

Ji-Yeon Kim

CONTACT

[email protected]

82-2-3410-3459

Mee Ryung Hong

CONTACT

[email protected]

82-2-2148-7147

Sponsors and collaborators

Lead sponsor

Samsung Medical Center

Other

Registry information

Official study title

Evaluation of Brain Metastasis Development Mechanism in Patients With Breast Cancer With Brain Metastasis(BCBM)

Important dates

Study start
2023
Primary completion
2025
Study completion
2027
First posted
Mar 26, 2024
Registry last updated
Mar 26, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.